SCHEMBL7823245

SCHEMBL7823245

Brc1cnc2c(c1)n[c]n2-c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA5 P31644 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
GABRA6 Q16445 1/20 0.33
ENPP3 O14638 1/20 0.33
ENPP1 P22413 1/20 0.33
HSD17B10 Q99714 1/20 0.33
AKT1 P31749 4/20 0.32
PTPN7 P35236 3/20 0.32
DUSP3 P51452 2/20 0.32
DYRK1A Q13627 2/20 0.32
DYRK1B Q9Y463 1/20 0.32
PLK4 O00444 1/20 0.32
AURKA O14965 1/20 0.32
JAK2 O60674 1/20 0.32
ROCK2 O75116 1/20 0.32
PRKD3 O94806 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7838386 0.73 HSD17B10 (0.43) HSD17B10DYRK1AHTTKMT2AMAPT
SCHEMBL7837631 0.73 KDM4E (0.42) HTTMAPTALDH1A1LMNA
SCHEMBL7838020 0.69 HSD17B10 (0.37) HSD17B10AKT1DYRK1A
SCHEMBL3940764 0.67 KDM4E (0.60) ENPP3ENPP1HSD17B10HDAC8HTT
SCHEMBL67806 0.66 HTT (0.42) HSD17B10FGFR1HTTRAB9AKMT2A
SCHEMBL13506216 0.66 AKT1 (0.43) HSD17B10AKT1PTPN7DUSP3HDAC8
SCHEMBL28543131 0.66 ENPP3 (0.47) ENPP3ENPP1HSD17B10DYRK1AAURKA
SCHEMBL19366827 0.64 ENPP3 (0.37) ENPP3ENPP1HSD17B10AKT1DYRK1A
SCHEMBL7832277 0.63 HCAR1 (0.33) HTTRAB9AMAPTSMN1; SMN2ALDH1A1
SCHEMBL5981936 0.63 ALDH1A1 (0.50) DYRK1AFGFR1HTTRAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed